Kumukova Irina (Irina Kumukova)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Candida Albicans

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Kumukova Irina, Elena Kurnikova, Pavel Trakhtman
Extracorporeal photopheresis: Is one ounce of blood enough? Case reports. Pediatric blood & cancer 71 (3) (2023)
Kumukova Irina, Kurnikova Elena, Trakhtman Pavel
Extracorporeal photopheresis: Is one ounce of blood enough? Case reports. Pediatric blood & cancer (2023)
Kumukova Irina, Elena Kurnikova, Pavel Trakhtman
Extracorporeal photopheresis: Is one ounce of blood enough? Case reports. Pediatric blood & cancer (2023)
Kumukova Irina, Elena Kurnikova, Pavel Trakhtman
Extracorporeal photopheresis: Is one ounce of blood enough? Case reports. Pediatric blood & cancer 71 (3) (2023)
Elena Kurnikova, Pavel Trakhtman, Dmitry Balashov, Juliya Garloeva, Kumukova Irina, Rimma Khismatullina, Dmitriy Pershin, Larisa Shelikhova, Galina A Novichkova, Alexey A Maschan
Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony-stimulating factor in healthy haploidentical stem cell donors. Vox sanguinis 117 (6) (2022)
Kumukova Irina, Nicolay Starostin, Pavel Trakhtman
Universal pathogen reduction in blood components is a close perspective. Vox sanguinis 116 (6) (2021)
Kumukova Irina, Pavel Trakhtman, Nicolay Starostin, Daria Borsakova, Anastasia Ignatova, Yana Bayzyanova
Quality assessment of red blood cell suspensions derived from pathogen-reduced whole blood. Vox sanguinis 116 (5) (2020)
Pavel Trakhtman, Kumukova Irina, Nikolay Starostin, Daria Borsakova, Dmitry Balashov, Anastasia A Ignatova, Leilya Kadaeva, Galina A Novichkova, Alexander Rumiantsev
The pathogen-reduced red blood cell suspension: single centre study of clinical safety and efficacy in children with oncological and haematological diseases. Vox sanguinis 114 (3) (2019)